NASDAQ:ADUS Addus HomeCare (ADUS) Stock Price, News & Analysis $126.37 -3.21 (-2.48%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$125.48▼$130.2150-Day Range$116.16▼$133.5852-Week Range$78.35▼$134.78Volume106,021 shsAverage Volume134,223 shsMarket Capitalization$2.29 billionP/E Ratio31.36Dividend YieldN/APrice Target$127.57 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Addus HomeCare alerts: Email Address Addus HomeCare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside1.0% Upside$127.57 Price TargetShort InterestHealthy2.23% of Shares Sold ShortDividend StrengthN/ASustainability-0.50Upright™ Environmental ScoreNews Sentiment0.58Based on 11 Articles This WeekInsider TradingSelling Shares$3.01 M Sold Last QuarterProj. Earnings Growth12.14%From $4.53 to $5.08 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.33 out of 5 starsMedical Sector116th out of 910 stocksHome Health Care Services Industry3rd out of 8 stocks 2.4 Analyst's Opinion Consensus RatingAddus HomeCare has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 7 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageAddus HomeCare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Addus HomeCare's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.23% of the outstanding shares of Addus HomeCare have been sold short.Short Interest Ratio / Days to CoverAddus HomeCare has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Addus HomeCare has recently increased by 3.50%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAddus HomeCare does not currently pay a dividend.Dividend GrowthAddus HomeCare does not have a long track record of dividend growth. Previous Next 5.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAddus HomeCare has received a 85.99% net impact score from Upright. The largest positive contribution comes from its "Meaning & joy" impact, which is mostly driven by its "Private hospice care", "Private occupational therapy services", and "Private home care for the elderly" products. See details.Environmental SustainabilityThe Environmental Impact score for Addus HomeCare is -0.50. Previous Next 2.0 News and Social Media Coverage News SentimentAddus HomeCare has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Addus HomeCare this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for ADUS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Addus HomeCare to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,011,532.00 in company stock.Percentage Held by InsidersOnly 4.60% of the stock of Addus HomeCare is held by insiders.Percentage Held by Institutions95.35% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Addus HomeCare's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Addus HomeCare are expected to grow by 12.14% in the coming year, from $4.53 to $5.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Addus HomeCare is 31.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.71.Price to Earnings Ratio vs. SectorThe P/E ratio of Addus HomeCare is 31.36, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.06.Price to Earnings Growth RatioAddus HomeCare has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAddus HomeCare has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Addus HomeCare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About Addus HomeCare Stock (NASDAQ:ADUS)Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Read More ADUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ADUS Stock News HeadlinesSeptember 7 at 9:25 AM | insidertrades.comEsteban Lopez Sells 500 Shares of Addus HomeCare Co. (NASDAQ:ADUS) StockAugust 29, 2024 | insidertrades.comAddus HomeCare Co. (NASDAQ:ADUS) EVP Sells $2,921,316.93 in StockSeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.September 5 at 4:39 PM | benzinga.comAddus HomeCare President and COO Sold $660K In Company StockSeptember 4 at 2:45 AM | americanbankingnews.comAddus HomeCare (NASDAQ:ADUS) Given "Outperform" Rating at Royal Bank of CanadaSeptember 3, 2024 | finance.yahoo.comInsider Sale: President and COO W Bickham Sells 5,000 Shares of Addus HomeCare Corp (ADUS)September 1, 2024 | americanbankingnews.comAddus HomeCare Co. (NASDAQ:ADUS) Receives $127.57 Consensus Target Price from AnalystsAugust 30, 2024 | americanbankingnews.comMichael D. Wattenbarger Sells 21,917 Shares of Addus HomeCare Co. (NASDAQ:ADUS) StockSeptember 7, 2024 | Porter & Company (Ad)War on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.August 28, 2024 | finance.yahoo.comInsider Sale: EVP/Chief Development Officer Cliff Blessing Sells 1,600 Shares of Addus HomeCare ...August 28, 2024 | finance.yahoo.comCalculating The Fair Value Of Addus HomeCare Corporation (NASDAQ:ADUS)August 16, 2024 | investing.comAddus HomeCare stock soars to all-time high of $129.19August 14, 2024 | finance.yahoo.comWe Think That There Are Issues Underlying Addus HomeCare's (NASDAQ:ADUS) EarningsAugust 13, 2024 | yahoo.comA new Colorado law opens the doors wider for ADUs. Here’s what it does — and doesn’t do.August 10, 2024 | uk.investing.comTD Cowen raises Addus HomeCare target on earnings outlookAugust 7, 2024 | msn.comAddus HomeCare Non-GAAP EPS of $1.35 beats by $0.13, revenue of $286.9M beats by $1.84MAugust 7, 2024 | finance.yahoo.comAddus HomeCare Announces Second Quarter 2024 Financial ResultsAugust 7, 2024 | seekingalpha.comAddus HomeCare Corporation (ADUS) Q2 2024 Earnings Call TranscriptSee More Headlines Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2024Today9/07/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Home health care services Sub-IndustryHealthcare Current SymbolNASDAQ:ADUS CUSIPN/A CIK1468328 Webwww.addus.com Phone(469) 535-8200Fax630-487-2707Employees34,846Year FoundedN/APrice Target and Rating Average Stock Price Target$127.57 High Stock Price Target$141.00 Low Stock Price Target$83.00 Potential Upside/Downside+1.0%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$4.03 Trailing P/E Ratio31.36 Forward P/E Ratio27.90 P/E Growth2.43Net Income$62.52 million Net Margins6.18% Pretax Margin8.20% Return on Equity9.81% Return on Assets7.11% Debt Debt-to-Equity RatioN/A Current Ratio2.00 Quick Ratio2.00 Sales & Book Value Annual Sales$1.11 billion Price / Sales2.05 Cash Flow$4.79 per share Price / Cash Flow26.36 Book Value$50.92 per share Price / Book2.48Miscellaneous Outstanding Shares18,095,000Free Float17,263,000Market Cap$2.29 billion OptionableOptionable Beta1.01 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. R. Dirk Allison (Age 68)CEO & Chairman of the Board Comp: $2.29MMr. W. Bradley Bickham (Age 61)President & COO Comp: $1.27MMr. Brian W. Poff (Age 50)CFO, Executive VP, Secretary & Treasurer Comp: $1.13MMr. Sean P. Gaffney (Age 44)Executive VP & Chief Legal Officer Comp: $759.42kMr. Darby Anderson (Age 58)Executive VP & Chief Government Relations Officer Comp: $826.77kMr. Zach SimpsonSenior VP & Chief Accounting OfficerMr. Michael D. Wattenbarger (Age 53)Executive VP & Chief Information Officer Comp: $391.11kMs. Monica Raines (Age 44)Executive VP and Chief Compliance & Quality Officer Comp: $538.17kMr. Roberton James Stevenson (Age 43)Executive VP & Chief Human Resource Officer Comp: $664.52kMs. Diane KumarichSenior Vice President of Payor InnovationMore ExecutivesKey CompetitorsAmedisysNASDAQ:AMEDLHC GroupNASDAQ:LHCGPACS GroupNYSE:PACSOption Care HealthNASDAQ:OPCHSotera HealthNASDAQ:SHCView All CompetitorsInsiders & InstitutionsSanctuary Advisors LLCBought 3,687 shares on 9/5/2024Ownership: 0.020%Ghisallo Capital Management LLCBought 100,000 shares on 9/4/2024Ownership: 0.553%Esteban LopezSold 500 sharesTotal: $65,015.00 ($130.03/share)Maven Securities LTDBought 9,000 shares on 8/29/2024Ownership: 0.050%Michael D WattenbargerSold 21,917 sharesTotal: $2.92 M ($133.29/share)View All Insider TransactionsView All Institutional Transactions ADUS Stock Analysis - Frequently Asked Questions How have ADUS shares performed this year? Addus HomeCare's stock was trading at $92.85 on January 1st, 2024. Since then, ADUS shares have increased by 36.1% and is now trading at $126.37. View the best growth stocks for 2024 here. How were Addus HomeCare's earnings last quarter? Addus HomeCare Co. (NASDAQ:ADUS) announced its earnings results on Monday, August, 5th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $1.21 by $0.14. The business's revenue for the quarter was up 10.4% on a year-over-year basis. What is Dirk Allison's approval rating as Addus HomeCare's CEO? 91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Who are Addus HomeCare's major shareholders? Addus HomeCare's top institutional shareholders include Point72 Asset Management L.P. (4.12%), Dimensional Fund Advisors LP (3.95%), Principal Financial Group Inc. (2.38%) and Millennium Management LLC (1.75%). Insiders that own company stock include R Dirk Allison, W Bradley Bickham, Darby Anderson, Brian Poff, Sean Gaffney, Monica Raines, Roberton James Stevenson, Michael D Wattenbarger and David W Tucker. View institutional ownership trends. How do I buy shares of Addus HomeCare? Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Addus HomeCare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS) and Pfizer (PFE). This page (NASDAQ:ADUS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.